Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 23
2001 27
2002 25
2003 36
2004 53
2005 41
2006 55
2007 44
2008 62
2009 84
2010 105
2011 229
2012 269
2013 120
2014 151
2015 131
2016 136
2017 132
2018 121
2019 128
2020 164
2021 179
2022 155
2023 163
2024 198
2025 219

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,050 results

Results by year

Filters applied: . Clear all
Page 1
Noncoding RNA Databases.
Allmer J. Allmer J. Curr Pharm Biotechnol. 2023;24(7):825-831. doi: 10.2174/1570180819666220520124511. Curr Pharm Biotechnol. 2023. PMID: 35619299
Editorial: Cosmeceutical Biotechnology.
Lin CC. Lin CC. Curr Pharm Biotechnol. 2015;16(12):1034. doi: 10.2174/138920101612150922194735. Curr Pharm Biotechnol. 2015. PMID: 26412222 No abstract available.
Oligonucleotide delivery system.
Teng L. Teng L. Curr Pharm Biotechnol. 2014;15(9):779. doi: 10.2174/138920101509141107121143. Curr Pharm Biotechnol. 2014. PMID: 25403515 No abstract available.
Biocompatible Nanomaterials for Burns.
Handa M, Maharana SK, Pal K, Shukla R. Handa M, et al. Curr Pharm Biotechnol. 2022;23(12):1514-1526. doi: 10.2174/1389201023666220413091055. Curr Pharm Biotechnol. 2022. PMID: 35422209 Review.
Antisense Agents against Antibiotic-resistant Bacteria.
Nezhadi J, Taghizadeh S, Khodadadi E, Yousefi M, Ganbarov K, Yousefi B, Leylabadlo HE, Asgharzadeh M, Tanomand A, Kazeminava F, Kafil HS. Nezhadi J, et al. Curr Pharm Biotechnol. 2022;23(15):1813-1823. doi: 10.2174/1389201023666220114160216. Curr Pharm Biotechnol. 2022. PMID: 35034590 Review.
Fibrinolytic Enzyme - An Overview.
Abdul Rahim P, Rengaswamy D. Abdul Rahim P, et al. Curr Pharm Biotechnol. 2022;23(11):1336-1345. doi: 10.2174/1389201023666220104143113. Curr Pharm Biotechnol. 2022. PMID: 34983344 Review.
AI in Health Science: A Perspective.
Mishra R, Chaudhary K, Mishra I. Mishra R, et al. Curr Pharm Biotechnol. 2023;24(9):1149-1163. doi: 10.2174/1389201023666220929145220. Curr Pharm Biotechnol. 2023. PMID: 36177622 Review.
Targeting Macrophages in Atherosclerosis.
Hu D, Wang Z, Wang Y, Liang C. Hu D, et al. Curr Pharm Biotechnol. 2021;22(15):2008-2018. doi: 10.2174/1389201022666210122142233. Curr Pharm Biotechnol. 2021. PMID: 33480337 Review.
3,050 results